Literature DB >> 32384908

Chloroquine for COVID-19: rationale, facts, hopes.

Andrea Cortegiani1, Mariachiara Ippolito2, Giulia Ingoglia2, Sharon Einav3.   

Abstract

Entities:  

Keywords:  COVID-19; Chloroquine; Coronavirus; Pneumonia; SARS-CoV-2

Year:  2020        PMID： 32384908     DOI： 10.1186/s13054-020-02932-4

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  6 in total

Review 1.  Clinical update on the use of mesenchymal stem cells in COVID-19.

Authors:  Fatima A Saleh; Joyce Ghazzawi
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

2.  Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.

Authors:  Andrea Cortegiani; Mariachiara Ippolito; Giulia Ingoglia; Pasquale Iozzo; Antonino Giarratano; Sharon Einav
Journal:  J Crit Care       Date:  2020-07-11       Impact factor: 3.425

3.  Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.

Authors:  A Cortegiani; M Ippolito; M Greco; V Granone; A Protti; C Gregoretti; A Giarratano; S Einav; M Cecconi
Journal:  Pulmonology       Date:  2020-07-20

4.  Retracted papers on SARS-CoV-2 and COVID-19.

Authors:  Andrea Cortegiani; Giulia Catalisano; Mariachiara Ippolito; Antonino Giarratano; Anthony R Absalom; Sharon Einav
Journal:  Br J Anaesth       Date:  2021-01-19       Impact factor: 9.166

5.  Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19.

Authors:  R K Hussein; H M Elkhair
Journal:  J Mol Struct       Date:  2021-01-25       Impact factor: 3.196

6.  Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.

Authors:  Orsolya Kapuy; Tamás Korcsmáros
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.